The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Modern Therapy of Acute Lymphoblastic Leukemia
Abstract
Although acute lymphoblastic leukemia is curable in one third of adult patients, results vary greatly on account of different clinical, immunologic, and cytogenetic/genetic characteristics. These data, along with the kinetics of response to early treatment, help establish the individual risk class with considerable accuracy, and support risk-specific treatments that should warrant optimal results with as little as possible nonrelapse mortality. Modern first-line therapy consists of standard- and high-dose chemotherapy (increasingly inspired to pediatric principles), hematopoietic stem-cell transplantation, and new targeted therapy, all integrated with the analysis of prognostic factors and the study of subclinical residual disease for key therapeutic decisions. These changes are improving long-term outcome, which in ongoing studies is expected close to 50% or greater.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Luznik, L., O'Donnell, P. V., Symons, H. J., Chen, A. R., Leffell, M. S., Zahurak, M., Gooley, T. A., Piantadosi, S., Kaup, M., Ambinder, R. F., et al. (2008) · Biology of Blood and Marrow Transplantation · doi:10.1016/j.bbmt.2008.03.005 · Cited by 1,938
Pui, C.-H., Robison, L. L., & Look, A. T. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60457-2 · Cited by 1,564
Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia
Coustan-Smith, E., Mullighan, C. G., Onciu, M., Behm, F. G., Raimondi, S. C., Pei, D., Cheng, C., Su, X., Rubnitz, J. E., Basso, G., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70314-0 · Cited by 1,019
Fielding, A. K., Richards, S. M., Chopra, R., Lazarus, H. M., Litzow, M. R., Buck, G., Durrant, I. J., Luger, S. M., Marks, D. I., Franklin, I. M., et al. (2007) · Blood · doi:10.1182/blood-2006-05-018192 · Cited by 841
Goldstone, A. H., Richards, S. M., Lazarus, H. M., Tallman, M. S., Buck, G., Fielding, A. K., Burnett, A. K., Chopra, R., Wiernik, P. H., Foroni, L., et al. (2008) · Blood · doi:10.1182/blood-2007-10-116582 · Cited by 778
Moorman, A. V., Harrison, C. J., Buck, G. A. N., Richards, S. M., Secker-Walker, L. M., Martineau, M., Vance, G. H., Cherry, A. M., Higgins, R. R., Fielding, A. K., et al. (2007) · Blood · doi:10.1182/blood-2006-10-051912 · Cited by 753
Schultz, K. R., Bowman, W. P., Aledo, A., Slayton, W. B., Sather, H., Devidas, M., Wang, C., Davies, S. M., Gaynon, P. S., Trigg, M., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.21.2514 · Cited by 701
Kantarjian, H., Thomas, D., O'Brien, S., Cortes, J., Giles, F., Jeha, S., Bueso‐Ramos, C. E., Pierce, S., Shan, J., Koller, C., et al. (2004) · Cancer · doi:10.1002/cncr.20668 · Cited by 638
Holleman, A., Cheok, M. H., den Boer, M. L., Yang, W., Veerman, A. J. P., Kazemier, K. M., Pei, D., Cheng, C., Pui, C.-H., Relling, M. V., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa033513 · Cited by 633
Larson, R., Dodge, R., Burns, C., Lee, E., Stone, R., Schulman, P., Duggan, D., Davey, F., Sobol, R., & Frankel, Sr. (1995) · Blood · doi:10.1182/blood.v85.8.2025.bloodjournal8582025 · Cited by 626
Thomas, D. A. (2004) · Blood · doi:10.1182/blood-2003-08-2958 · Cited by 571
Huguet, F., Leguay, T., Raffoux, E., Thomas, X., Beldjord, K., Delabesse, E., Chevallier, P., Buzyn, A., Delannoy, A., Chalandon, Y., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.6916 · Cited by 567
Outcome of Treatment in Adults With Acute Lymphoblastic Leukemia: Analysis of the LALA-94 Trial
Thomas, X., Boiron, J.-M., Huguet, F., Dombret, H., Bradstock, K., Vey, N., Kovacsovics, T., Delannoy, A., Fegueux, N., Fenaux, P., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.10.050 · Cited by 550
Brüggemann, M., Raff, T., Flohr, T., Gökbuget, N., Nakao, M., Droese, J., Lüschen, S., Pott, C., Ritgen, M., Scheuring, U., et al. (2006) · Blood · doi:10.1182/blood-2005-07-2708 · Cited by 537
Self-citationStock, W., La, M., Sanford, B., Bloomfield, C. D., Vardiman, J. W., Gaynon, P., Larson, R. A., & Nachman, J. (2008) · Blood · doi:10.1182/blood-2008-01-130237 · Cited by 534
Yanada, M., Takeuchi, J., Sugiura, I., Akiyama, H., Usui, N., Yagasaki, F., Kobayashi, T., Ueda, Y., Takeuchi, M., Miyawaki, S., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.2177 · Cited by 454
Bassan, R., Spinelli, O., Oldani, E., Intermesoli, T., Tosi, M., Peruta, B., Rossi, G., Borlenghi, E., Pogliani, E. M., Terruzzi, E., et al. (2009) · Blood · doi:10.1182/blood-2008-11-185132 · Cited by 430
Self-citationMarks, D. I., Paietta, E. M., Moorman, A. V., Richards, S. M., Buck, G., DeWald, G., Ferrando, A., Fielding, A. K., Goldstone, A. H., Ketterling, R. P., et al. (2009) · Blood · doi:10.1182/blood-2009-08-231217 · Cited by 420
Vignetti, M., Fazi, P., Cimino, G., Martinelli, G., Di Raimondo, F., Ferrara, F., Meloni, G., Ambrosetti, A., Quarta, G., Pagano, L., et al. (2007) · Blood · doi:10.1182/blood-2006-10-052746 · Cited by 374
Annino, L., Vegna, M. L., Camera, A., Specchia, G., Visani, G., Fioritoni, G., Ferrara, F., Peta, A., Ciolli, S., Deplano, W., et al. (2002) · Blood · doi:10.1182/blood.v99.3.863 · Cited by 352
Chiaretti, S., Li, X., Gentleman, R., Vitale, A., Vignetti, M., Mandelli, F., Ritz, J., & Foa, R. (2004) · Blood · doi:10.1182/blood-2003-09-3243 · Cited by 351
Ravandi, F., O'Brien, S., Thomas, D., Faderl, S., Jones, D., Garris, R., Dara, S., Jorgensen, J., Kebriaei, P., Champlin, R., et al. (2010) · Blood · doi:10.1182/blood-2009-12-261586 · Cited by 348
de Labarthe, A., Rousselot, P., Huguet-Rigal, F., Delabesse, E., Witz, F., Maury, S., Réa, D., Cayuela, J.-M., Vekemans, M.-C., Reman, O., et al. (2007) · Blood · doi:10.1182/blood-2006-03-011908 · Cited by 344
Brüggemann, M., Schrauder, A., Raff, T., Pfeifer, H., Dworzak, M., Ottmann, O. G., Asnafi, V, Baruchel, A., Bassan, R., Benoit, Y., et al. (2010) · Leukemia · doi:10.1038/leu.2009.268 · Cited by 341
Self-citationImproved outcome in adult B-cell acute lymphoblastic leukemia
Hoelzer, D., Ludwig, W., Thiel, E., Gassmann, W., Loffler, H., Fonatsch, C., Rieder, H., Heil, G., Heinze, B., Arnold, R., et al. (1996) · Blood · doi:10.1182/blood.v87.2.495.bloodjournal872495 · Cited by 314
Self-citationFielding, A. K., Rowe, J. M., Richards, S. M., Buck, G., Moorman, A. V., Durrant, I. J., Marks, D. I., McMillan, A. K., Litzow, M. R., Lazarus, H. M., et al. (2009) · Blood · doi:10.1182/blood-2009-01-199380 · Cited by 291
Brockman, M. A., Kwon, D. S., Tighe, D. P., Pavlik, D. F., Rosato, P. C., Sela, J., Porichis, F., Le Gall, S., Waring, M. T., Moss, K., et al. (2009) · Blood · doi:10.1182/blood-2008-12-191296 · Cited by 286
Ciceri, F., Labopin, M., Aversa, F., Rowe, J. M., Bunjes, D., Lewalle, P., Nagler, A., Di Bartolomeo, P., Lacerda, J. F., Lupo Stanghellini, M. T., et al. (2008) · Blood · doi:10.1182/blood-2008-02-140095 · Cited by 279
Bassan, R., Rossi, G., Pogliani, E. M., Di Bona, E., Angelucci, E., Cavattoni, I., Lambertenghi-Deliliers, G., Mannelli, F., Levis, A., Ciceri, F., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.28.1287 · Cited by 272
Self-citationCCR7 signalling as an essential regulator of CNS infiltration in T-cell leukaemia
Buonamici, S., Trimarchi, T., Ruocco, M. G., Reavie, L., Cathelin, S., Mar, B. G., Klinakis, A., Lukyanov, Y., Tseng, J.-C., Sen, F., et al. (2009) · Nature · doi:10.1038/nature08020 · Cited by 263
Ribera, J.-M., Oriol, A., Sanz, M.-A., Tormo, M., Fernández-Abellán, P., del Potro, E., Abella, E., Bueno, J., Parody, R., Bastida, P., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.13.7265 · Cited by 263
Lazarus, H. M. (2006) · Blood · doi:10.1182/blood-2005-11-4666 · Cited by 253
Ottmann, O. G., Wassmann, B., Pfeifer, H., Giagounidis, A., Stelljes, M., Dührsen, U., Schmalzing, M., Wunderle, L., Binckebanck, A., & Hoelzer, D. (2007) · Cancer · doi:10.1002/cncr.22631 · Cited by 250
Self-citationAsnafi, V., Buzyn, A., Le Noir, S., Baleydier, F., Simon, A., Beldjord, K., Reman, O., Witz, F., Fagot, T., Tavernier, E., et al. (2009) · Blood · doi:10.1182/blood-2008-10-184069 · Cited by 246
Pulte, D., Gondos, A., & Brenner, H. (2009) · Blood · doi:10.1182/blood-2008-06-164863 · Cited by 234
The role of NOTCH1 signaling in T-ALL
Ferrando, A. A. (2009) · Hematology · doi:10.1182/asheducation-2009.1.353 · Cited by 203
Jabbour, E., O'Brien, S., Kantarjian, H., Garcia-Manero, G., Ferrajoli, A., Ravandi, F., Cabanillas, M., & Thomas, D. A. (2007) · Blood · doi:10.1182/blood-2006-08-043646 · Cited by 193
Barry, E., DeAngelo, D. J., Neuberg, D., Stevenson, K., Loh, M. L., Asselin, B. L., Barr, R. D., Clavell, L. A., Hurwitz, C. A., Moghrabi, A., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.08.6397 · Cited by 192
Ribera, J.-M., Oriol, A., Gonzalez, M., Vidriales, B., Brunet, S., Esteve, J., del Potro, E., Rivas, C., Moreno, M.-J., Tormo, M., et al. (2010) · Haematologica · doi:10.3324/haematol.2009.011221 · Cited by 189
Cornelissen, J. J., van der Holt, B., Verhoef, G. E. G., van 't Veer, M. B., van Oers, M. H. J., Schouten, H. C., Ossenkoppele, G., Sonneveld, P., Maertens, J., van Marwijk Kooy, M., et al. (2009) · Blood · doi:10.1182/blood-2008-07-168625 · Cited by 173
Gaynor, J., Chapman, D., Little, C., McKenzie, S., Miller, W., Andreeff, M., Arlin, Z., Berman, E., Kempin, S., & Gee, T. (1988) · Journal of Clinical Oncology · doi:10.1200/jco.1988.6.6.1014 · Cited by 170
Chiaretti, S., Li, X., Gentleman, R. C., Vitale, A., Wang, K. S., Mandelli, F., Foà, R., & Ritz, J. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2165 · Cited by 158
Oliansky, D. M., Appelbaum, F., Cassileth, P. A., Keating, A., Kerr, J., Nieto, Y., Stewart, S., Stone, R. M., Tallman, M. S., McCarthy, P. L., et al. (2008) · Biology of Blood and Marrow Transplantation · doi:10.1016/j.bbmt.2007.11.002 · Cited by 158
Storring, J. M., Minden, M. D., Kao, S., Gupta, V. K., Schuh, A. C., Schimmer, A. D., Yee, K. W. L., Kamel‐Reid, S., Chang, H., Lipton, J. H., et al. (2009) · British Journal of Haematology · doi:10.1111/j.1365-2141.2009.07712.x · Cited by 153
Delannoy, A., Delabesse, É., Lhéritier, V., Castaigné, S., Huguet, F., Raffoux, E., Garban, F., Legrand, O., Bologna, S., Dubruille, V., et al. (2006) · Leukemia · doi:10.1038/sj.leu.2404320 · Cited by 114
Hahn, T., Wall, D. A., Camitta, B. M., Davies, S. M., Dillon, H., Gaynon, P. S., Larson, R. A., Parsons, S. K., Seidenfeld, J., Weisdorf, D. J., et al. (2006) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2005.10.018 · Cited by 112
Tafuri, A. (2002) · Blood · doi:10.1182/blood-2001-12-0371 · Cited by 110
Baldus, C. D., Burmeister, T., Martus, P., Schwartz, S., Gökbuget, N., Bloomfield, C. D., Hoelzer, D. F., Thiel, E., & Hofmann, W. K. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.06.1580 · Cited by 110
Self-citationBaldus, C. D., Martus, P., Burmeister, T., Schwartz, S., Gökbuget, N., Bloomfield, C. D., Hoelzer, D. F., Thiel, E., & Hofmann, W. K. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.11.5253 · Cited by 100
Self-citationFigueroa, M. E., Wouters, B. J., Skrabanek, L. A., Glass, J. L., Li, Y., Erpelinck-Verschueren, C. A. J., Langerak, A. W., Löwenberg, B., Fazzari, M. J., Greally, J. M., et al. (2009) · Blood · doi:10.1182/blood-2008-08-172387 · Cited by 91
End points to establish the efficacy of new agents in the treatment of acute leukemia
Appelbaum, F. R., Rosenblum, D., Arceci, R. J., Carroll, W. L., Breitfeld, P. P., Forman, S. J., Larson, R. A., Lee, S. J., Murphy, S. B., O'Brien, S. M., et al. (2006) · Blood · doi:10.1182/blood-2006-08-041152 · Cited by 91
Mohty, M., de Lavallade, H., Cheikh, J. E., Ladaique, P., Faucher, C., Fürst, S., Vey, N., Coso, D., Stoppa, A. M., Gastaut, J. A., et al. (2008) · Leukemia · doi:10.1038/leu.2008.164 · Cited by 49
Structural Aspects of Hepcidin-Ferroportin Binding
Preza, G. C., Fernandes, A. O., Clark, R. J., Craik, D. J., Ganz, T., & Nemeth, E. (2008) · Blood · doi:10.1182/blood.v112.11.119.119 · Cited by 5
Bhattacharyya, S., & Muglia, L. J. (2009) · Blood · doi:10.1182/blood.v114.22.239.239 · Cited by 2
Cited by
Blinatumomab versus Chemotherapy for Advanced Acute Lymphoblastic Leukemia
Kantarjian, H., Stein, A., Gökbuget, N., Fielding, A. K., Schuh, A. C., Ribera, J.-M., Wei, A., Dombret, H., Foà, R., Bassan, R., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1609783 · Cited by 2,143
Self-citationBrentjens, R. J., Rivière, I., Park, J. H., Davila, M. L., Wang, X., Stefanski, J., Taylor, C., Yeh, R., Bartido, S., Borquez-Ojeda, O., et al. (2011) · Blood · doi:10.1182/blood-2011-04-348540 · Cited by 1,286
Inaba, H., Greaves, M., & Mullighan, C. G. (2013) · The Lancet · doi:10.1016/s0140-6736(12)62187-4 · Cited by 1,074
Gökbuget, N., Dombret, H., Bonifacio, M., Reichle, A., Graux, C., Faul, C., Diedrich, H., Topp, M. S., Brüggemann, M., Horst, H.-A., et al. (2018) · Blood · doi:10.1182/blood-2017-08-798322 · Cited by 858
Malard, F., & Mohty, M. (2020) · The Lancet · doi:10.1016/s0140-6736(19)33018-1 · Cited by 773
Metadata
- Authors
- Bassan, R., & Hoelzer, D.
- Venue
- Journal of Clinical Oncology
- Published
- 2011-02-10
- Volume
- 29
- Issue
- 5
- Pages
- 532-543
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2081127271
- Cited by
- 485
- References
- 56
- FWCI
- 37.92
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.